Sign in
CompletedNo phase

Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product

Key facts

Who runs it
Becton, Dickinson and Company
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
394 people enrolled
Started
26 Jun 2024
Ended
23 Oct 2025
Type of study
Observational, 2 groups
Treatments tested
  • test Aerobic/F Culture Vials
  • control Aerobic/F Culture Vials
Record updated
20 November 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Subject is willing to provide written informed consent to sponsor
  • Blood specimens
  • Patients with suspected blood infection that have one or more of the following characteristics :; Body temperature > 38°C or body temperature <36°C; b) chills; c) increased peripheral blood leukocyte count (count > 10.0×109/L, especially if there is a "left shift") or decrease (count < 3.0×109/L); d) Respiratory rate > 20 beats/min or arterial partial pressure of carbon dioxide (PaCO2) <32mmHg; e) Heart rate> 90 beats/min; f) mucocutaneous hemorrhage; g) coma; h) Multi-organ dysfunction; i) decreased blood pressure; j) Elevated inflammatory response parameters such as C-reactive protein or hypersensitive C-reactive protein, procalcitonin (PCT), 1,3-β-D-glucan (G test), etc

Who cannot take part

  • Patients with severe and very severe anemia (last hemoglobin <60g/L within seven days)
  • Subjects have been enrolled in this study and samples have been collected
  • Females with known pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a multi-center, randomized clinical validation. Subjects should be fully informed of this protocol and related risks, and can only be enrolled into this study after signing the informed consent form. Blood collection of the subjects at the same puncture point at a single site will be injected into the test vial and the control vial respectively, and the vials will be transferred to the BACTEC system for culture and the results will be observed. After the BACTEC system incubation completion, the vials will be subcultured. Strains grown on plates will be identified using appropriate methods and, if possible, at the species level.

The 2 groups in the trial

  • BD BACTEC™ Plus Aerobic/F Culture Vials(test)

    Additional blood sample collected compared to clinical routine care

    Treatment: test Aerobic/F Culture Vials

  • BD BACTEC™ Plus Aerobic/F Culture Vials(control)

    clinical routine care

    Treatment: control Aerobic/F Culture Vials

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 November 2025